A tale of two cohorts: are we overestimating the risk of colorectal cancer in inflammatory bowel disease?
GC Nguyen, B Bressler - Gastroenterology, 2012 - gastrojournal.org
See “Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over
30 years,” by Jess T, Simonsen J, Jørgensen KT, et al, on page 375; and “Incidence and
mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from
1998 to 2010,” by Herrinton LJ, Liu L, Levin TR, et al, on page 382. Colorectal cancer (CRC)
has been widely accepted as a long-term complication of inflammatory bowel disease (IBD).
A meta-analysis from 2001 showed that the cumulative risks of colon cancer among those …
30 years,” by Jess T, Simonsen J, Jørgensen KT, et al, on page 375; and “Incidence and
mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from
1998 to 2010,” by Herrinton LJ, Liu L, Levin TR, et al, on page 382. Colorectal cancer (CRC)
has been widely accepted as a long-term complication of inflammatory bowel disease (IBD).
A meta-analysis from 2001 showed that the cumulative risks of colon cancer among those …
